| BioID | bio3320 |
| Name | RAVOXERTINIB |
| ChEMBL ID | CHEMBL3544964 |
| Molecular Formula | C21H18ClFN6O2 |
| Molecular Weight | 440.87 |
| Molecular Weight (Monoisotopic) | 440.1164 |
| Type | Small molecule |
| Max Phase | Phase 2 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | GDC-0994|GDC0994|RAVOXERTINIB|RG-7842 |
| Smiles | Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1 |
| Inchi | InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1 |
| Inchi Key | RZUOCXOYPYGSKL-GOSISDBHSA-N |
| Molecular Species | NEUTRAL |
| Targets | 293.0 |
| Bioactivities | 370.0 |
| Np Likeness Score | -1.67 |
| Records Key | ['GDC-0994', 'GDC-0994, RG-7842', '3; GDC-0994', 'Ravoxertinib', 'RAVOXERTINIB', '3; GDC-0994', 'BDBM120095', '4; GDC-0994', '22; GDC-0994', 'RAVOXERTINIB', 'GDC-0994', 'GDC-0994', 'Ravoxertinib', 'BDBM120095', 'RAVOXERTINIB', 'GDC-0994', 'Ravoxertinib', 'EOS101780'] |
| Records Name | ['GDC-0994', '(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-(1-methyl-1H-pyrazol-5-ylamino)pyrimidin-4-yl)pyridin-2(1H)-one', '(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-(1-methyl-1H-pyrazol-5-ylamino)pyrimidin-4-yl)pyridin-2(1H)-one', 'Ravoxertinib', 'RAVOXERTINIB', '1-[(1S)-1-(4-chloro-3-fluoro-phenyl)-2-hydroxy-ethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one', 'US8697715, 39::US9259470, 39', '1-[(1S)-1-(4-chloro-3-fluoro-phenyl)-2-hydroxy-ethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one', '(S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one', 'RAVOXERTINIB', 'GDC-0994', 'GDC-0994', 'Ravoxertinib', 'US8697715, 39::US9259470, 39', 'RAVOXERTINIB', 'GDC-0994', 'Ravoxertinib', 'ravoxertinib'] |
| Withdrawn Flag | False |
| Orphan | 0 |